✦ LIBER ✦

Two-Dose Daclizumab, Tacrolimus, Mycophenolate Mofetil, and Steroid-Free Regimen in De Novo Cardiac Transplant Recipients: Early Experience

✍ Scribed by S. Mastrobuoni; M. Ubilla; A. Cordero; J. Herreros; G. Rabago

Book ID: 116933592
Publisher: Elsevier Science
Year: 2007
Tongue: English
Weight: 109 KB
Volume: 39
Category: Article
ISSN: 0041-1345
DOI: 10.1016/j.transproceed.2007.06.073

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Steroid-free regimen with daclizumab, my

Steroid-free regimen with daclizumab, mycophenolate mofetil, and tacrolimus in liver transplant recipients

✍ J Figueras; A Bernardos; M Prieto; M Gómez; A Rimola; J Ortiz de Urbina; V Cuerv 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 55 KB

Evaluation of renal function in liver tr

Evaluation of renal function in liver transplant recipients receiving daclizumab (Zenapax), mycophenolate mofetil, and a delayed, low-dose tacrolimus regimen vs. a standard-dose tacrolimus and mycophenolate mofetil regimen: A multicenter randomized clinical trial

✍ Eric M. Yoshida; Paul J. Marotta; Paul D. Greig; Norman M. Kneteman; Denis Marle 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 111 KB

Posttransplant chronic renal failure, secondary to calcineurin inhibitor agents, is emerging as a major problem in liver transplantation. We report a randomized clinical trial comparing daclizumab, delayed low-dose tacrolimus (target trough level 4-8 ng/mL, starting day 4-6), Investigational Arm (n

Wound Healing Complications with De Novo

Wound Healing Complications with De Novo Sirolimus Versus Mycophenolate Mofetil-Based Regimen in Cardiac Transplant Recipients

✍ S. Kuppahally; A. Al-Khaldi; D. Weisshaar; H. A. Valantine; P. Oyer; R. C. Robbi 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 71 KB

Efficacy and cardiovascular safety of da

Efficacy and cardiovascular safety of daclizumab, mycophenolate mofetil, tacrolimus, and early steroid withdrawal in renal transplant recipients: a multicenter, prospective, pilot trial

✍ Daniel Abramowicz; Yves Vanrenterghem; Jean-Paul Squifflet; Dirk Kuypers; Michel 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 131 KB

Prospective Clinical Trial Comparing Two

Prospective Clinical Trial Comparing Two Immunosuppressive Regimens, Tacrolimus and Mycophenolate Mofetil Versus Everolimus and Low-Dose Cyclosporine, in De Novo Renal Transplant Recipients: Results at 6 Months Follow-up

✍ E. Favi; F. Citterio; G. Spagnoletti; A. Gargiulo; F. Delreno; J. Romagnoli; M. 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 113 KB

Cardiovascular Risk Profile in Kidney Tr

Cardiovascular Risk Profile in Kidney Transplant Recipients Treated With Two Immunosuppressive Regimens: Tacrolimus and Mycophenolate Mofetil Versus Everolimus and Low-Dose Cyclosporine

✍ G. Spagnoletti; F. Citterio; E. Favi; E. Rossi; F. Delreno; I. De Santis; M.P. S 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 104 KB